Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Cortesi

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Future Oncology (London, England)|June 16, 2018
Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of careGiuseppe De Vincentis, Fabio Monari, Sergio Baldari, et al.
Journal of Cellular and Molecular Medicine|March 1, 2011
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymalAngela Gradilone, Cristina Raimondi, Chiara Nicolazzo, et al.
The Oncologist|July 22, 2004
Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapyEnrico Cortesi, Andrea Mancuso, Adolfo De Pasquale Ceratti, et al.
Clinical Colorectal Cancer|July 25, 2008
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicitiesTeresa Gamucci, Fabrizio Nelli, Giovanni Cianci, et al.
Oncotarget|May 16, 2022
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational studyCarolina Sciortino, Valentina Viglialoro, Massimo Nucci, et al.
Abdominal Radiology (New York)|December 17, 2021
Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary reportMartina Pecoraro, Francesco Del Giudice, Fabio Magliocca, et al.
Anticancer Research|June 25, 2003
Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastasesRaffaello Mancini, Manfredo Tedesco, Carlo Garufi, et al.
Cancer|October 10, 2003
Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter studyFilippo De Marinis, Fabrizio Nelli, Maria Rita Migliorino, et al.
Breast (Edinburgh, Scotland)|March 26, 2013
Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 casesMaurizio Cardi, Paolo Sammartino, Maria Luisa Framarino, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2020
Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experienceAlessandro Sciarra, Stefano Salciccia, Martina Maggi, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Future Oncology (London, England)|June 16, 2018
Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of careGiuseppe De Vincentis, Fabio Monari, Sergio Baldari, et al.
Journal of Cellular and Molecular Medicine|March 1, 2011
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymalAngela Gradilone, Cristina Raimondi, Chiara Nicolazzo, et al.
The Oncologist|July 22, 2004
Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapyEnrico Cortesi, Andrea Mancuso, Adolfo De Pasquale Ceratti, et al.
Clinical Colorectal Cancer|July 25, 2008
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicitiesTeresa Gamucci, Fabrizio Nelli, Giovanni Cianci, et al.
Oncotarget|May 16, 2022
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational studyCarolina Sciortino, Valentina Viglialoro, Massimo Nucci, et al.
Abdominal Radiology (New York)|December 17, 2021
Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary reportMartina Pecoraro, Francesco Del Giudice, Fabio Magliocca, et al.
Anticancer Research|June 25, 2003
Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastasesRaffaello Mancini, Manfredo Tedesco, Carlo Garufi, et al.
Cancer|October 10, 2003
Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter studyFilippo De Marinis, Fabrizio Nelli, Maria Rita Migliorino, et al.
Breast (Edinburgh, Scotland)|March 26, 2013
Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 casesMaurizio Cardi, Paolo Sammartino, Maria Luisa Framarino, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2020
Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experienceAlessandro Sciarra, Stefano Salciccia, Martina Maggi, et al.
Pageof 18